Phibro Animal Health (NASDAQ:PAHC) Sets New 52-Week High at $22.81

Phibro Animal Health Co. (NASDAQ:PAHC)’s share price hit a new 52-week high on Monday . The stock traded as high as $22.81 and last traded at $22.53, with a volume of 147848 shares. The stock had previously closed at $22.07.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on PAHC. Bank of America raised their target price on Phibro Animal Health from $13.00 to $15.00 and gave the stock an “underperform” rating in a research report on Friday, August 30th. JPMorgan Chase & Co. started coverage on Phibro Animal Health in a research note on Tuesday, September 10th. They issued a “neutral” rating and a $22.00 price target for the company. Three equities research analysts have rated the stock with a sell rating, two have given a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $15.00.

Phibro Animal Health Stock Performance

The stock has a fifty day simple moving average of $19.75 and a two-hundred day simple moving average of $17.26. The company has a debt-to-equity ratio of 1.79, a quick ratio of 1.64 and a current ratio of 2.94. The stock has a market capitalization of $912.06 million, a price-to-earnings ratio of 70.38, a P/E/G ratio of 1.77 and a beta of 0.52.

Phibro Animal Health (NASDAQ:PAHC) last issued its earnings results on Wednesday, August 28th. The company reported $0.41 earnings per share for the quarter, topping analysts’ consensus estimates of $0.34 by $0.07. The business had revenue of $273.16 million during the quarter, compared to the consensus estimate of $262.44 million. Phibro Animal Health had a return on equity of 18.08% and a net margin of 0.24%. Analysts forecast that Phibro Animal Health Co. will post 1.44 earnings per share for the current fiscal year.

Phibro Animal Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, September 25th. Investors of record on Wednesday, September 4th were given a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a yield of 2.13%. The ex-dividend date was Wednesday, September 4th. Phibro Animal Health’s payout ratio is 150.00%.

Insiders Place Their Bets

In other news, Director E Thomas Corcoran bought 5,000 shares of the stock in a transaction dated Wednesday, September 4th. The shares were bought at an average cost of $20.02 per share, with a total value of $100,100.00. Following the completion of the transaction, the director now directly owns 25,000 shares of the company’s stock, valued at $500,500. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 50.06% of the company’s stock.

Institutional Investors Weigh In On Phibro Animal Health

A number of institutional investors and hedge funds have recently made changes to their positions in the business. CWM LLC raised its stake in shares of Phibro Animal Health by 89.8% in the second quarter. CWM LLC now owns 2,188 shares of the company’s stock worth $37,000 after purchasing an additional 1,035 shares during the last quarter. Fidelis Capital Partners LLC purchased a new stake in Phibro Animal Health in the 1st quarter valued at $46,000. China Universal Asset Management Co. Ltd. raised its position in Phibro Animal Health by 65.0% in the 1st quarter. China Universal Asset Management Co. Ltd. now owns 3,888 shares of the company’s stock valued at $50,000 after buying an additional 1,531 shares during the last quarter. Summit Securities Group LLC bought a new position in Phibro Animal Health during the 2nd quarter valued at $83,000. Finally, Illinois Municipal Retirement Fund boosted its holdings in Phibro Animal Health by 7.2% during the 1st quarter. Illinois Municipal Retirement Fund now owns 11,430 shares of the company’s stock worth $148,000 after acquiring an additional 765 shares during the last quarter. Institutional investors and hedge funds own 99.34% of the company’s stock.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.